Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
67.54 (1y: +137%)
Market Cap 1.79 B P/E(ttm) 87.20
Enterprise Value 1.67 B P/B 12.60
MDSO- NAS (USA)
Medidata Solutions, Inc.
Not Rated
Top Ranked Predictable Companies
$67.54
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry		 vs
history
Cash to Debt 790.671
MDSO's Cash to Debt is ranked higher than
55% of the 1027 Companies
in the Global Software - Application industry.

( Industry Median: 51.37 vs. MDSO: 790.671 )
MDSO' s 10-Year Cash to Debt Range
Min: 0.4   Max: No Debt
Current: 790.67
Equity to Asset 0.556
MDSO's Equity to Asset is ranked higher than
52% of the 876 Companies
in the Global Software - Application industry.

( Industry Median: 0.54 vs. MDSO: 0.556 )
MDSO' s 10-Year Equity to Asset Range
Min: -1.75   Max: 0.56
Current: 0.56
-1.75
0.56
Interest Coverage No Debt
MDSO's Interest Coverage is ranked lower than
55% of the 797 Companies
in the Global Software - Application industry.

( Industry Median: 10000.00 vs. MDSO: No Debt )
MDSO' s 10-Year Interest Coverage Range
Min: 5   Max: No Debt
Current: No Debt
F-Score: 5
Z-Score: 16.23
M-Score: -1.71
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry		 vs
history
Operating margin (%) 12.80
MDSO's Operating margin (%) is ranked higher than
63% of the 759 Companies
in the Global Software - Application industry.

( Industry Median: 9.00 vs. MDSO: 12.80 )
MDSO' s 10-Year Operating margin (%) Range
Min: -36.2   Max: 14
Current: 12.8
-36.2
14
Net-margin (%) 8.3
MDSO's Net-margin (%) is ranked higher than
54% of the 736 Companies
in the Global Software - Application industry.

( Industry Median: 7.30 vs. MDSO: 8.3 )
MDSO' s 10-Year Net-margin (%) Range
Min: -52.4   Max: 21.4
Current: 8.3
-52.4
21.4
ROE (%) 12.7
MDSO's ROE (%) is ranked higher than
64% of the 728 Companies
in the Global Software - Application industry.

( Industry Median: 9.90 vs. MDSO: 12.7 )
MDSO' s 10-Year ROE (%) Range
Min: 12.7   Max: 44.6
Current: 12.7
12.7
44.6
ROA (%) 8
MDSO's ROA (%) is ranked higher than
65% of the 733 Companies
in the Global Software - Application industry.

( Industry Median: 5.90 vs. MDSO: 8 )
MDSO' s 10-Year ROA (%) Range
Min: -53.2   Max: 20.8
Current: 8
-53.2
20.8
Revenue Growth (%) 6.1
MDSO's Revenue Growth (%) is ranked lower than
67% of the 417 Companies
in the Global Software - Application industry.

( Industry Median: 9.00 vs. MDSO: 6.1 )
MDSO' s 10-Year Revenue Growth (%) Range
Min: -16.7   Max: 6.1
Current: 6.1
-16.7
6.1
ยป MDSO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

MDSO Guru Trades in Q2 2012

Steven Cohen 382,510 sh (-49.12%)
Joel Greenblatt 16,667 sh (-51.69%)
» More
Q3 2012

MDSO Guru Trades in Q3 2012

Joel Greenblatt 14,827 sh (-11.04%)
Steven Cohen 252,213 sh (-34.06%)
» More
Q4 2012

MDSO Guru Trades in Q4 2012

Jim Simons 59,757 sh (New)
Joel Greenblatt Sold Out
Steven Cohen 1,100 sh (-99.56%)
» More
Q1 2013

MDSO Guru Trades in Q1 2013

Tom Russo 81 sh (New)
Chuck Royce 20,000 sh (New)
Jim Simons 85,547 sh (+43.16%)
Steven Cohen Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MDSO

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2012-12-31 Sold Out 0.04%$37.38 - $42.85 $ 67.5470%0
Joel Greenblatt 2012-06-30 Reduce -51.69%0.04%$24.55 - $32.67 $ 67.54146%16667
Joel Greenblatt 2012-03-31 Reduce -27.73%0.04%$18.61 - $27.65 $ 67.54227%34499
Joel Greenblatt 2011-09-30 Add 310.24%0.09%$14.53 - $24.48 $ 67.54264%45007
Lee Ainslie 2011-06-30 Sold Out 0.13%$21.4 - $26.12 $ 67.54183%0
Joel Greenblatt 2011-06-30 New Buy0.04%$21.4 - $26.12 $ 67.54183%10971
Lee Ainslie 2011-03-31 Reduce -44.59%0.1%$22.98 - $27.11 $ 67.54166%485479
Lee Ainslie 2010-09-30 Add 58.89%0.08%$15.06 - $19.3 $ 67.54307%1022190
Lee Ainslie 2010-06-30 New Buy0.13%$13.64 - $16.42 $ 67.54352%643331
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 87.20
MDSO's P/E(ttm) is ranked lower than
90% of the 745 Companies
in the Global Software - Application industry.

( Industry Median: 20.80 vs. MDSO: 87.20 )
MDSO' s 10-Year P/E(ttm) Range
Min: 11.44   Max: 167.73
Current: 87.2
11.44
167.73
P/B 12.60
MDSO's P/B is ranked lower than
95% of the 996 Companies
in the Global Software - Application industry.

( Industry Median: 2.00 vs. MDSO: 12.60 )
MDSO' s 10-Year P/B Range
Min: 4.46   Max: 24.14
Current: 12.6
4.46
24.14
P/S 7.50
MDSO's P/S is ranked lower than
89% of the 1037 Companies
in the Global Software - Application industry.

( Industry Median: 1.60 vs. MDSO: 7.50 )
MDSO' s 10-Year P/S Range
Min: 2   Max: 8.03
Current: 7.5
2
8.03
PFCF 250.30
MDSO's PFCF is ranked lower than
96% of the 710 Companies
in the Global Software - Application industry.

( Industry Median: 18.06 vs. MDSO: 250.30 )
MDSO' s 10-Year PFCF Range
Min: 13.25   Max: 266.59
Current: 250.3
13.25
266.59
EV-to-EBIT 58.8
MDSO's EV-to-EBIT is ranked lower than
86% of the 818 Companies
in the Global Software - Application industry.

( Industry Median: 15.61 vs. MDSO: 58.8 )
MDSO' s 10-Year EV-to-EBIT Range
Min: 8.8   Max: 82.8
Current: 58.8
8.8
82.8

Valuation & Return

vs
industry		 vs
history
Price/Net Cash 44.7
MDSO's Price/Net Cash is ranked lower than
86% of the 386 Companies
in the Global Software - Application industry.

( Industry Median: 8.90 vs. MDSO: 44.7 )
MDSO' s 10-Year Price/Net Cash Range
Min: 24.4   Max: 25
Current: 44.7
24.4
25
Price/Net Current Asset Value 53.6
MDSO's Price/Net Current Asset Value is ranked lower than
85% of the 709 Companies
in the Global Software - Application industry.

( Industry Median: 11.80 vs. MDSO: 53.6 )
MDSO' s 10-Year Price/Net Current Asset Value Range
Min: 23.2   Max: 29.9
Current: 53.6
23.2
29.9
Price/Tangible Book 14.3
MDSO's Price/Tangible Book is ranked lower than
91% of the 863 Companies
in the Global Software - Application industry.

( Industry Median: 3.00 vs. MDSO: 14.3 )
MDSO' s 10-Year Price/Tangible Book Range
Min: 6.3   Max: 53.9
Current: 14.3
6.3
53.9
Price/Median PS Value 2.4
MDSO's Price/Median PS Value is ranked lower than
91% of the 992 Companies
in the Global Software - Application industry.

( Industry Median: 1.10 vs. MDSO: 2.4 )
MDSO' s 10-Year Price/Median PS Value Range
Min: 0.7   Max: 1.5
Current: 2.4
0.7
1.5
Price/Graham Number 7.6
MDSO's Price/Graham Number is ranked lower than
94% of the 651 Companies
in the Global Software - Application industry.

( Industry Median: 1.80 vs. MDSO: 7.6 )
MDSO' s 10-Year Price/Graham Number Range
Min: 1.9   Max: 12.2
Current: 7.6
1.9
12.2
Earnings Yield (Greenblatt) 1.70
MDSO's Earnings Yield (Greenblatt) is ranked lower than
84% of the 826 Companies
in the Global Software - Application industry.

( Industry Median: 6.20 vs. MDSO: 1.70 )
MDSO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.2   Max: 11.3
Current: 1.7
1.2
11.3

Business Description

Medidata Solutions, Inc. was organized as a New York corporation in June 1999 and reincorporated in the State of Delaware in May 2000. It provides hosted clinical development solutions that enhance the efficiency of its customers' clinical development processes and optimize their research and development investments. The Company's solutions allow its customers to achieve clinical results by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development, contract research organization negotiation, investigator contracting, the capture and management of clinical trial data and the analysis and reporting of that data on a worldwide basis. Its customers include pharmaceutical, biotechnology and medical device companies, academic institutions, contract research organizations, or CROs, and other organizations engaged in clinical trials to bring innovative medical products to market and explore new indications for existing medical products. The Company's customers rely on its solutions to safely accelerate the clinical development process and maximize the commercial life of their products. Its main offering, Medidata Rave, is a comprehensive platform that integrates electronic data capture, or EDC, with a clinical data management system, or CDMS, in a single solution that replaces traditional paper-based methods of capturing and managing clinical data. Medidata Rave offers a robust, flexible platform enabling sponsors to manage increasingly complex trials. Medidata Rave's intuitive, user-friendly Internet-based technology facilitates rapid adoption by investigators, sponsors and CROs. The Rave platform is based on industry standards, and provides interoperability for applications throughout the development process. In addition, its on-demand, hosted technology platform facilitates rapid and cost-effective deployment of its solutions on a global basis. The Company has designed its Medidata Rave software to scale reliably and cost-effectively for clinical trials of all sizes and phases, including those involving substantial numbers of clinical sites and patients worldwide. It also offers applications that improve efficiencies in protocol development and trial planning, contracting and negotiation. Its Medidata Designer application, a clinical trial protocol authoring tool, enables customers to write trial protocols more effectively and automatically configure Medidata Rave. Medidata offers a broad set of advanced technology solutions aimed at achieving efficiencies across the clinical research process in order to lower the total cost of clinical development at its customers. Its competitors include BioClinica, Datatrak International, Merge Healthcare, OmniComm Systems, Oracle and Perceptive Informatics. As well as it faces competition at the clinical data product level from independent companies such as TTC LLC and ClearTrial, LLC.
Company Website
SEC Reports
Industry: Software - Application
Compare:
Traded in other countries:2M9.Germany
ยป More Articles for MDSO

Headlines

Articles On GuruFocus.com
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,667 Shares Mar 08 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,000 Shares Mar 03 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 13,667 Shares Feb 07 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 3,000 Shares Feb 03 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 13,667 Shares Jan 10 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 3,000 Shares Jan 05 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,998 Shares Dec 08 2010 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 11,000 Shares Dec 03 2010 
Medidata Solutions Inc. (MDSO) EVP & CFO Bruce D Dalziel sells 12,000 Shares Nov 23 2010 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 17,998 Shares Nov 22 2010 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial